Impax Asset Management Group plc Buys 10,830 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Impax Asset Management Group plc lifted its stake in shares of Mettler-Toledo International Inc. (NYSE:MTDFree Report) by 5.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 198,852 shares of the medical instruments supplier’s stock after purchasing an additional 10,830 shares during the quarter. Mettler-Toledo International accounts for about 1.1% of Impax Asset Management Group plc’s holdings, making the stock its 28th largest position. Impax Asset Management Group plc owned about 0.94% of Mettler-Toledo International worth $243,331,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in MTD. Blue Trust Inc. increased its position in shares of Mettler-Toledo International by 242.9% during the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 17 shares during the period. Ashton Thomas Securities LLC purchased a new position in Mettler-Toledo International during the third quarter valued at approximately $37,000. Sound Income Strategies LLC increased its holdings in Mettler-Toledo International by 4,500.0% during the 4th quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier’s stock worth $56,000 after acquiring an additional 45 shares during the period. Huntington National Bank lifted its stake in Mettler-Toledo International by 20.0% in the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock worth $81,000 after purchasing an additional 9 shares in the last quarter. Finally, Itau Unibanco Holding S.A. boosted its holdings in Mettler-Toledo International by 80.0% in the 3rd quarter. Itau Unibanco Holding S.A. now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after purchasing an additional 24 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of NYSE MTD opened at $1,285.67 on Monday. The stock has a market capitalization of $26.90 billion, a P/E ratio of 31.72, a PEG ratio of 3.30 and a beta of 1.13. Mettler-Toledo International Inc. has a one year low of $1,142.91 and a one year high of $1,546.93. The firm’s 50 day simple moving average is $1,285.56 and its two-hundred day simple moving average is $1,332.98.

Mettler-Toledo International (NYSE:MTDGet Free Report) last issued its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. As a group, equities analysts expect that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on MTD. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating on the stock. Robert W. Baird upped their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Stifel Nicolaus dropped their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their price objective for the stock from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Finally, Wells Fargo & Company lifted their target price on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday, February 10th. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $1,368.00.

Get Our Latest Report on Mettler-Toledo International

Insider Activity

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now owns 6 shares of the company’s stock, valued at $8,108.04. This represents a 99.01 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.94% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Read More

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.